DK0758890T3 - Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne - Google Patents

Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne

Info

Publication number
DK0758890T3
DK0758890T3 DK95918128T DK95918128T DK0758890T3 DK 0758890 T3 DK0758890 T3 DK 0758890T3 DK 95918128 T DK95918128 T DK 95918128T DK 95918128 T DK95918128 T DK 95918128T DK 0758890 T3 DK0758890 T3 DK 0758890T3
Authority
DK
Denmark
Prior art keywords
migraine
treatment
catchers
antagonists
inhibitors
Prior art date
Application number
DK95918128T
Other languages
English (en)
Inventor
Jes Olesen
Original Assignee
Jes Olesen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jes Olesen filed Critical Jes Olesen
Application granted granted Critical
Publication of DK0758890T3 publication Critical patent/DK0758890T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
DK95918128T 1994-05-11 1995-05-10 Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne DK0758890T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94610027 1994-05-11
PCT/IB1995/000415 WO1995031195A1 (en) 1994-05-11 1995-05-10 Use of no scavengers, inhibitors or antagonists in the treatment of migraine
EP95918128A EP0758890B1 (en) 1994-05-11 1995-05-10 Use of no scavengers, inhibitors or antagonists in the treatment of migraine

Publications (1)

Publication Number Publication Date
DK0758890T3 true DK0758890T3 (da) 2005-04-18

Family

ID=8218183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95918128T DK0758890T3 (da) 1994-05-11 1995-05-10 Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne

Country Status (12)

Country Link
US (1) US6265441B1 (da)
EP (1) EP0758890B1 (da)
JP (2) JPH10500129A (da)
AT (1) ATE291909T1 (da)
AU (1) AU704059B2 (da)
CA (1) CA2189762C (da)
DE (1) DE69534118T2 (da)
DK (1) DK0758890T3 (da)
ES (1) ES2238074T3 (da)
PT (1) PT758890E (da)
SI (1) SI0758890T1 (da)
WO (1) WO1995031195A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6284794B1 (en) 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
EP1829539A3 (en) * 1996-11-05 2008-02-20 HEADEXPLORER ApS A method for treating tension-type headache
AU1824300A (en) * 1998-11-23 2000-06-13 Linden Biotechnology, Inc. Combination products of a guanylate cyclase inhibitor and a local anesthetic forpain relief
EP1562975A2 (en) * 2002-10-25 2005-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroid compounds comprising superoxide dismutase mimic groups and nitric oxide donor groups, and their use in the preparation of medicaments
US20060166894A1 (en) * 2002-11-29 2006-07-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ace-inhibitors having antioxidant and no-donor activity
US20080274206A1 (en) * 2004-10-07 2008-11-06 Ngen Pharmaceuticals N.V. Stabilised Oxygen Releasing Composition
WO2007009462A2 (en) * 2005-07-15 2007-01-25 Region Hovedstaden V/Glostrup Hospital Treatment of migraine and headaches
US20090191283A1 (en) * 2008-01-24 2009-07-30 Oronsky Bryan Todd Treatment of headaches, neck pain, joint pain and inflammatory-type pain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
FR2707494B1 (fr) * 1993-07-02 1995-08-25 Roussel Uclaf Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.
PL180081B1 (pl) * 1993-08-12 2000-12-29 Astra Ab Nowe pochodne amidyny i sposób ich wytwarzania PL PL PL PL PL PL PL
GB9317686D0 (en) 1993-08-25 1993-10-13 Johnson Matthey Plc Pharmaceutical compositions
CA2188680A1 (en) * 1994-05-07 1996-01-25 James Edwin Macdonald Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase

Also Published As

Publication number Publication date
ATE291909T1 (de) 2005-04-15
CA2189762C (en) 2009-01-13
EP0758890A1 (en) 1997-02-26
CA2189762A1 (en) 1995-11-23
WO1995031195A1 (en) 1995-11-23
US6265441B1 (en) 2001-07-24
AU2417995A (en) 1995-12-05
JP2007137906A (ja) 2007-06-07
ES2238074T3 (es) 2005-08-16
DE69534118T2 (de) 2006-02-09
DE69534118D1 (de) 2005-05-04
PT758890E (pt) 2005-06-30
SI0758890T1 (da) 2005-08-31
JPH10500129A (ja) 1998-01-06
EP0758890B1 (en) 2005-03-30
AU704059B2 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
DK0971713T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsforstyrrelser
DK1355889T3 (da) Substituerede triazoldiaminderivater som kinaseinhibitorer
HRP20000292B1 (hr) 2-fenil supstituirani imidazotriazinoni kao inhibitori fosfodiesteraze
DK0804196T3 (da) Anvendelse af serotoninantagonister (5HT 3) til behandling af fibromyalgia
TR199801348T2 (xx) Heterosikl-kondanse morfinoid t�revleri(II).
DE59707502D1 (de) Holzschutzmittel für den nachschutz
ATE217321T1 (de) Aromatische heterocyclische derivate als enzyminhibitoren
ID18142A (id) Inhibitor metaloprotease 1,4-heterosiklik
ATE247470T1 (de) Neue substituierte imidazolverbindungen
EA200300906A1 (ru) Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7
FI945411A0 (fi) Viilentäviä koostumuksia
NO20032625D0 (no) Indazolylsubstituerte pyrrolinforbindelser som kineaseinhibitorer
EA199800633A1 (ru) Новые замещенные производные имидазола
ATE266399T1 (de) Neue substituierte triazolverbindungen
DK0528858T3 (da) Inhibitorer af dipeptidyl-aminopeptidase type IV
ATE214276T1 (de) Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
EA199900837A1 (ru) Способ применения ингибиторов циклооксигеназы-2 для предупреждения сердечно-сосудистых расстройств
EP0787016A4 (en) SECRETORY LEUCOCYTE PROTEASE INHIBITOR USED AS TRYPTASE INHIBITOR
ATE193647T1 (de) Di- und trivalente kleine moleküle als selektininhibitoren
DK0758890T3 (da) Anvendelse af NO indfangere, inhibitorer eller antagonister ved behandling af migræne
EA200400734A1 (ru) Способ и композиция для потенциирования действия опиатного анальгетика
AR028730A1 (es) Procedimiento para encontrar compuestos que son adecuados para el tratamiento y/o la profilaxis de la obesidad y utilizacion de dichos compuestos
ES2146249T3 (es) Composicion farmaceutica para tratar la impotencia que contiene un inhibidor alfa-1 y un inhibidor alfa-2.
PT941975E (pt) Cimento para injeccao contendo inibidores de corrosao
EA200300978A1 (ru) Ингибирование поглощения моноамина